BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Annet L, Materne R, Danse E, Jamart J, Horsmans Y, Van Beers BE. Hepatic flow parameters measured with MR imaging and Doppler US: correlations with degree of cirrhosis and portal hypertension. Radiology. 2003;229:409-414. [PMID: 12970464 DOI: 10.1148/radiol.2292021128] [Cited by in Crossref: 211] [Cited by in F6Publishing: 179] [Article Influence: 11.7] [Reference Citation Analysis]
Number Citing Articles
1 Takahashi H, Suzuki M, Ikeda H, Kobayashi M, Sase S, Yotsuyanagi H, Maeyama S, Iino S, Itoh F. Evaluation of quantitative portal venous, hepatic arterial, and total hepatic tissue blood flow using xenon CT in alcoholic liver cirrhosis: comparison with liver cirrhosis C. Alcohol Clin Exp Res. 2007;31:S43-S48. [PMID: 17331165 DOI: 10.1111/j.1530-0277.2006.00285.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
2 Kim JH, Lee JM, Yoon JH, Lee DH, Lee KB, Han JK, Choi BI. Portal Vein Thrombosis in Patients with Hepatocellular Carcinoma: Diagnostic Accuracy of Gadoxetic Acid-enhanced MR Imaging. Radiology. 2016;279:773-783. [PMID: 26780538 DOI: 10.1148/radiol.2015150124] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 3.2] [Reference Citation Analysis]
3 Gharib AM, Han MAT, Meissner EG, Kleiner DE, Zhao X, McLaughlin M, Matthews L, Rizvi B, Abd-Elmoniem KZ, Sinkus R, Levy E, Koh C, Myers RP, Subramanian GM, Kottilil S, Heller T, Kovacs JA, Morse CG. Magnetic Resonance Elastography Shear Wave Velocity Correlates with Liver Fibrosis and Hepatic Venous Pressure Gradient in Adults with Advanced Liver Disease. Biomed Res Int 2017;2017:2067479. [PMID: 28480218 DOI: 10.1155/2017/2067479] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 5.0] [Reference Citation Analysis]
4 Pan X, Qian T, Fernandez-Seara MA, Smith RX, Li K, Ying K, Sung K, Wang DJ. Quantification of liver perfusion using multidelay pseudocontinuous arterial spin labeling. J Magn Reson Imaging 2016;43:1046-54. [PMID: 26445928 DOI: 10.1002/jmri.25070] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
5 Agnello F, Dioguardi Burgio M, Picone D, Vernuccio F, Cabibbo G, Giannitrapani L, Taibbi A, Agrusa A, Bartolotta TV, Galia M. Magnetic resonance imaging of the cirrhotic liver in the era of gadoxetic acid. World J Gastroenterol. 2016;22:103-111. [PMID: 26755863 DOI: 10.3748/wjg.v22.i1.103] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 6] [Article Influence: 2.8] [Reference Citation Analysis]
6 Huwart L, Sempoux C, Salameh N, Jamart J, Annet L, Sinkus R, Peeters F, ter Beek LC, Horsmans Y, Van Beers BE. Liver fibrosis: noninvasive assessment with MR elastography versus aspartate aminotransferase-to-platelet ratio index. Radiology. 2007;245:458-466. [PMID: 17940304 DOI: 10.1148/radiol.2452061673] [Cited by in Crossref: 297] [Cited by in F6Publishing: 251] [Article Influence: 21.2] [Reference Citation Analysis]
7 Patel J, Sigmund EE, Rusinek H, Oei M, Babb JS, Taouli B. Diagnosis of cirrhosis with intravoxel incoherent motion diffusion MRI and dynamic contrast-enhanced MRI alone and in combination: preliminary experience. J MagnReson Imaging. 2010;31:589-600. [PMID: 20187201 DOI: 10.1002/jmri.22081] [Cited by in Crossref: 286] [Cited by in F6Publishing: 258] [Article Influence: 26.0] [Reference Citation Analysis]
8 Popov D, Krasteva R, Ivanova R, Mateva L, Krastev Z. Doppler parameters of hepatic and renal hemodynamics in patients with liver cirrhosis. Int J Nephrol 2012;2012:961654. [PMID: 22811907 DOI: 10.1155/2012/961654] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
9 Chouhan MD, Bainbridge A, Atkinson D, Punwani S, Mookerjee RP, Lythgoe MF, Taylor SA. Estimation of contrast agent bolus arrival delays for improved reproducibility of liver DCE MRI. Phys Med Biol 2016;61:6905-18. [PMID: 27618594 DOI: 10.1088/0031-9155/61/19/6905] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
10 Bahl G, Cruite I, Wolfson T, Gamst AC, Collins JM, Chavez AD, Barakat F, Hassanein T, Sirlin CB. Noninvasive classification of hepatic fibrosis based on texture parameters from double contrast-enhanced magnetic resonance images. J Magn Reson Imaging 2012;36:1154-61. [PMID: 22851409 DOI: 10.1002/jmri.23759] [Cited by in Crossref: 41] [Cited by in F6Publishing: 33] [Article Influence: 4.6] [Reference Citation Analysis]
11 Willmann S, Coboeken K, Kapsa S, Thelen K, Mundhenke M, Fischer K, Hügl B, Mück W. Applications of Physiologically Based Pharmacokinetic Modeling of Rivaroxaban-Renal and Hepatic Impairment and Drug-Drug Interaction Potential. J Clin Pharmacol 2021;61:656-65. [PMID: 33205449 DOI: 10.1002/jcph.1784] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Taouli B, Chouli M, Martin AJ, Qayyum A, Coakley FV, Vilgrain V. Chronic hepatitis: role of diffusion-weighted imaging and diffusion tensor imaging for the diagnosis of liver fibrosis and inflammation. J Magn Reson Imaging. 2008;28:89-95. [PMID: 18581382 DOI: 10.1002/jmri.21227] [Cited by in Crossref: 152] [Cited by in F6Publishing: 139] [Article Influence: 11.7] [Reference Citation Analysis]
13 Wagner M, Hectors S, Bane O, Gordic S, Kennedy P, Besa C, Schiano TD, Thung S, Fischman A, Taouli B. Noninvasive prediction of portal pressure with MR elastography and DCE-MRI of the liver and spleen: Preliminary results. J Magn Reson Imaging 2018;48:1091-103. [PMID: 29638020 DOI: 10.1002/jmri.26026] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 5.3] [Reference Citation Analysis]
14 Scharf J, Kemmling A, Hess T, Mehrabi A, Kauffmann G, Groden C, Brix G. Assessment of Hepatic Perfusion in Transplanted Livers by Pharmacokinetic Analysis of Dynamic Magnetic Resonance Measurements: . Investigative Radiology 2007;42:224-9. [DOI: 10.1097/01.rli.0000255892.07208.f2] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
15 Johnson TN, Boussery K, Rowland-Yeo K, Tucker GT, Rostami-Hodjegan A. A semi-mechanistic model to predict the effects of liver cirrhosis on drug clearance. Clin Pharmacokinet. 2010;49:189-206. [PMID: 20170207 DOI: 10.2165/11318160-000000000-00000] [Cited by in Crossref: 124] [Cited by in F6Publishing: 106] [Article Influence: 11.3] [Reference Citation Analysis]
16 Ronot M, Asselah T, Paradis V, Michoux N, Dorvillius M, Baron G, Marcellin P, Van Beers BE, Vilgrain V. Liver fibrosis in chronic hepatitis C virus infection: differentiating minimal from intermediate fibrosis with perfusion CT. Radiology. 2010;256:135-142. [PMID: 20574090 DOI: 10.1148/radiol.10091295] [Cited by in Crossref: 97] [Cited by in F6Publishing: 81] [Article Influence: 8.8] [Reference Citation Analysis]
17 Van Beers BE, Daire JL, Garteiser P. New imaging techniques for liver diseases. J Hepatol. 2015;62:690-700. [PMID: 25457198 DOI: 10.1016/j.jhep.2014.10.014] [Cited by in Crossref: 64] [Cited by in F6Publishing: 52] [Article Influence: 9.1] [Reference Citation Analysis]
18 Jajamovich GH, Dyvorne H, Donnerhack C, Taouli B. Quantitative liver MRI combining phase contrast imaging, elastography, and DWI: assessment of reproducibility and postprandial effect at 3.0 T. PLoS One. 2014;9:e97355. [PMID: 24840288 DOI: 10.1371/journal.pone.0097355] [Cited by in Crossref: 50] [Cited by in F6Publishing: 41] [Article Influence: 7.1] [Reference Citation Analysis]
19 Chouhan MD, Lythgoe MF, Mookerjee RP, Taylor SA. Vascular assessment of liver disease-towards a new frontier in MRI. Br J Radiol. 2016;89:20150675. [PMID: 27115318 DOI: 10.1259/bjr.20150675] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
20 Onur MR, Poyraz AK, Bozdag PG, Onder S, Aygun C. Diffusion weighted MRI in chronic viral hepatitis: correlation between ADC values and histopathological scores. Insights Imaging. 2013;4:339-345. [PMID: 23666523 DOI: 10.1007/s13244-013-0252-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
21 Aronhime S, Calcagno C, Jajamovich GH, Dyvorne HA, Robson P, Dieterich D, Fiel MI, Martel-Laferriere V, Chatterji M, Rusinek H. DCE-MRI of the liver: effect of linear and nonlinear conversions on hepatic perfusion quantification and reproducibility. J Magn Reson Imaging. 2014;40:90-98. [PMID: 24923476 DOI: 10.1002/jmri.24341] [Cited by in Crossref: 26] [Cited by in F6Publishing: 19] [Article Influence: 3.3] [Reference Citation Analysis]
22 Reyal J, Uemoto S. Percutaneously adjustable portal vein banding device could prevent post-operative liver failure – Artificial control of portal venous flow is the key to a new therapeutic world. Medical Hypotheses 2009;73:640-50. [DOI: 10.1016/j.mehy.2009.08.018] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
23 Cresswell A, Wendon J. HEPATIC FUNCTION AND NON-INVASIVE HEPATOSPLANCHNIC MONITORING IN PATIENTS WITH ABDOMINAL HYPERTENSION. Acta Clinica Belgica 2014;62:113-8. [DOI: 10.1179/acb.2007.62.s1.014] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
24 Bonekamp S, Torbenson MS, Kamel IR. Diffusion-weighted magnetic resonance imaging for the staging of liver fibrosis. J Clin Gastroenterol. 2011;45:885-892. [PMID: 21716125 DOI: 10.1097/mcg.0b013e318223bd2c] [Cited by in Crossref: 69] [Cited by in F6Publishing: 29] [Article Influence: 7.7] [Reference Citation Analysis]
25 Sonnemans LJ, Köster N, Prokop M, van der Laak JA, Klein WM. Liver parenchyma at the site of hypodense parafissural pseudolesion contains increased collagen. Abdom Imaging 2015;40:2306-12. [PMID: 25952576 DOI: 10.1007/s00261-015-0442-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
26 Saito K, Ledsam J, Sourbron S, Otaka J, Araki Y, Akata S, Tokuuye K. Assessing liver function using dynamic Gd-EOB-DTPA-enhanced MRI with a standard 5-phase imaging protocol. J Magn Reson Imaging. 2013;37:1109-1114. [PMID: 23086736 DOI: 10.1002/jmri.23907] [Cited by in Crossref: 42] [Cited by in F6Publishing: 38] [Article Influence: 4.7] [Reference Citation Analysis]
27 Zhang Y, Jin N, Deng J, Guo Y, White SB, Yang GY, Omary RA, Larson AC. Intra-voxel incoherent motion MRI in rodent model of diethylnitrosamine-induced liver fibrosis. Magn Reson Imaging 2013;31:1017-21. [PMID: 23598061 DOI: 10.1016/j.mri.2013.03.007] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 2.6] [Reference Citation Analysis]
28 Shen L, Li JQ, Zeng MD, Lu LG, Fan ST, Bao H. Correlation between ultrasonographic and pathologic diagnosis of liver fibrosis due to chronic virus hepatitis. World J Gastroenterol. 2006;12:1292-1295. [PMID: 16534888 DOI: 10.3748/wjg.v12.i8.1292] [Cited by in CrossRef: 41] [Cited by in F6Publishing: 38] [Article Influence: 2.7] [Reference Citation Analysis]
29 Zhang Q, Yu NN, Wen LJ, Liu GL, Tang J, Yuan ZG, Liu ZQ. A preliminary study of apparent diffusion coefficient in chemotherapy-induced liver damage. Eur J Radiol 2012;81:2943-6. [PMID: 22260894 DOI: 10.1016/j.ejrad.2011.12.025] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
30 Chandarana H, Block TK, Ream J, Mikheev A, Sigal SH, Otazo R, Rusinek H. Estimating liver perfusion from free-breathing continuously acquired dynamic gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced acquisition with compressed sensing reconstruction. Invest Radiol 2015;50:88-94. [PMID: 25333309 DOI: 10.1097/RLI.0000000000000105] [Cited by in Crossref: 36] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
31 Koh DM, Padhani AR. Functional magnetic resonance imaging of the liver: parametric assessments beyond morphology. Magn Reson Imaging Clin N Am 2010;18:565-85, xii. [PMID: 21094456 DOI: 10.1016/j.mric.2010.07.002] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
32 Okada M, Murakami T, Yada N, Numata K, Onoda M, Hyodo T, Inoue T, Ishii K, Kudo M. Comparison between T1 relaxation time of Gd-EOB-DTPA-enhanced MRI and liver stiffness measurement of ultrasound elastography in the evaluation of cirrhotic liver: Comparison Between T1 Map and FibroScan. J Magn Reson Imaging 2015;41:329-38. [DOI: 10.1002/jmri.24529] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
33 Chen BB, Hsu CY, Yu CW, Kao JH, Lee HS, Liang PC, Wei SY, Hwang RM, Shih TT. Hepatic necro-inflammation and elevated liver enzymes: evaluation with MRI perfusion imaging with gadoxetic acid in chronic hepatitis patients. Clin Radiol. 2014;69:473-480. [PMID: 24556468 DOI: 10.1016/j.crad.2013.12.003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
34 Mwangi I, Hanna RF, Kased N, Malek P, Shiehmorteza M, Wolfson T, Gamst A, Sirlin C. Apparent Diffusion Coefficient of Fibrosis and Regenerative Nodules in the Cirrhotic Liver at MRI. American Journal of Roentgenology 2010;194:1515-22. [DOI: 10.2214/ajr.09.3484] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
35 Kang HJ, Kim YI, Kim HC, Jae HJ, Hur S, Chung JW. Does Establishing a Safety Margin Reduce Local Recurrence in Subsegmental Transarterial Chemoembolization for Small Nodular Hepatocellular Carcinomas? Korean J Radiol 2015;16:1068-78. [PMID: 26357501 DOI: 10.3348/kjr.2015.16.5.1068] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
36 Im WH, Song JS, Jang W. Noninvasive staging of liver fibrosis: review of current quantitative CT and MRI-based techniques. Abdom Radiol (NY) 2021. [PMID: 34228199 DOI: 10.1007/s00261-021-03181-x] [Reference Citation Analysis]
37 Barash H, Gross E, Edrei Y, Pappo O, Spira G, Vlodavsky I, Galun E, Matot I, Abramovitch R. Functional magnetic resonance imaging monitoring of pathological changes in rodent livers during hyperoxia and hypercapnia. Hepatology. 2008;48:1232-1241. [PMID: 18629804 DOI: 10.1002/hep.22394] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 1.7] [Reference Citation Analysis]
38 Koh TS, Thng CH, Lee PS, Hartono S, Rumpel H, Goh BC, Bisdas S. Hepatic metastases: in vivo assessment of perfusion parameters at dynamic contrast-enhanced MR imaging with dual-input two-compartment tracer kinetics model. Radiology. 2008;249:307-320. [PMID: 18695207 DOI: 10.1148/radiol.2483071958] [Cited by in Crossref: 80] [Cited by in F6Publishing: 67] [Article Influence: 6.2] [Reference Citation Analysis]
39 Taouli B, Ehman RL, Reeder SB. Advanced MRI methods for assessment of chronic liver disease. AJR Am J Roentgenol. 2009;193:14-27. [PMID: 19542391 DOI: 10.2214/ajr.09.2601] [Cited by in Crossref: 128] [Cited by in F6Publishing: 44] [Article Influence: 10.7] [Reference Citation Analysis]
40 Wu H, Zhou N, Lu L, Chen X, Liu T, Zhang B, Liu H, Wen Z. Value of preoperative computed tomography for meso-Rex bypass in children with extrahepatic portal vein obstruction. Insights Imaging 2021;12:109. [PMID: 34318352 DOI: 10.1186/s13244-021-01057-8] [Reference Citation Analysis]
41 Luna A, Pahwa S, Bonini C, Alcalá-Mata L, Wright KL, Gulani V. Multiparametric MR Imaging in Abdominal Malignancies. Magn Reson Imaging Clin N Am 2016;24:157-86. [PMID: 26613880 DOI: 10.1016/j.mric.2015.08.005] [Cited by in Crossref: 21] [Cited by in F6Publishing: 13] [Article Influence: 4.2] [Reference Citation Analysis]
42 Berzigotti A, Nicolau C, Bellot P, Abraldes JG, Gilabert R, García-Pagan JC, Bosch J. Evaluation of regional hepatic perfusion (RHP) by contrast-enhanced ultrasound in patients with cirrhosis. J Hepatol. 2011;55:307-314. [PMID: 21167236 DOI: 10.1016/j.jhep.2010.10.038] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 2.7] [Reference Citation Analysis]
43 Stankovic Z, Frydrychowicz A, Csatari Z, Panther E, Deibert P, Euringer W, Kreisel W, Russe M, Bauer S, Langer M. MR-based visualization and quantification of three-dimensional flow characteristics in the portal venous system. J Magn Reson Imaging. 2010;32:466-475. [PMID: 20677279 DOI: 10.1002/jmri.22248] [Cited by in Crossref: 38] [Cited by in F6Publishing: 34] [Article Influence: 3.5] [Reference Citation Analysis]
44 Weber A, Krebs S, Lenhardt C, Wagenpfeil S, Schmid RM, Schulte-Frohlinde E. Correlation of routinely used coagulation parameters and presence of portal vein thrombosis in patients with liver cirrhosis. Hepatol Res. 2009;39:882-887. [PMID: 19619258 DOI: 10.1111/j.1872-034X.2009.00531.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
45 Stankovic Z, Allen BD, Garcia J, Jarvis KB, Markl M. 4D flow imaging with MRI. Cardiovasc Diagn Ther. 2014;4:173-192. [PMID: 24834414 DOI: 10.3978/j.issn.2223-3652.2014.01.02] [Cited by in F6Publishing: 56] [Reference Citation Analysis]
46 Yzet T, Bouzerar R, Allart JD, Demuynck F, Legallais C, Robert B, Deramond H, Meyer ME, Balédent O. Hepatic vascular flow measurements by phase contrast MRI and doppler echography: a comparative and reproducibility study. J Magn Reson Imaging. 2010;31:579-588. [PMID: 20187200 DOI: 10.1002/jmri.22079] [Cited by in Crossref: 51] [Cited by in F6Publishing: 36] [Article Influence: 4.6] [Reference Citation Analysis]
47 Pinzani M, Rombouts K, Colagrande S. Fibrosis in chronic liver diseases: diagnosis and management. J Hepatol. 2005;42 Suppl:S22-S36. [PMID: 15777570 DOI: 10.1016/j.jhep.2004.12.008] [Cited by in Crossref: 163] [Cited by in F6Publishing: 143] [Article Influence: 9.6] [Reference Citation Analysis]
48 Carollo V, Marrone G, Cortis K, Mamone G, Caruso S, Milazzo M, Maruzzelli L, di Francesco F, Delle M, Miraglia R, de Ville de Goyet J. Multimodality imaging of the Meso-Rex bypass. Abdom Radiol (NY) 2019;44:1379-94. [PMID: 30467724 DOI: 10.1007/s00261-018-1836-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
49 O'Brien CB. The hospitalized patient with abnormal liver function tests. Clin Liver Dis 2009;13:179-92. [PMID: 19442913 DOI: 10.1016/j.cld.2009.02.010] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
50 Yu Y, Guo L, Hu C, Chen K. Spectral CT imaging in the differential diagnosis of necrotic hepatocellular carcinoma and hepatic abscess. Clin Radiol 2014;69:e517-24. [PMID: 25248290 DOI: 10.1016/j.crad.2014.08.018] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
51 Artiko VM, Sobić-Saranović DP, Pavlović SV, Perisić-Savić MS, Stojković MV, Radoman IB, Knezević SJ, Vlajković MZ, Obradović VB. Estimation of the relative liver perfusion using two methods of radionuclide angiography in the patients with hemodynamic disorders in the portal system. Acta Chir Iugosl 2008;55:11-6. [PMID: 18510056 DOI: 10.2298/aci0801011a] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
52 Chouhan MD, Bainbridge A, Atkinson D, Punwani S, Mookerjee RP, Lythgoe MF, Taylor SA. Improved hepatic arterial fraction estimation using cardiac output correction of arterial input functions for liver DCE MRI. Phys Med Biol 2017;62:1533-46. [PMID: 28002045 DOI: 10.1088/1361-6560/aa553c] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
53 Taylor MD, Clewell HJ 3rd, Andersen ME, Schroeter JD, Yoon M, Keene AM, Dorman DC. Update on a Pharmacokinetic-Centric Alternative Tier II Program for MMT-Part II: Physiologically Based Pharmacokinetic Modeling and Manganese Risk Assessment. J Toxicol 2012;2012:791431. [PMID: 22645610 DOI: 10.1155/2012/791431] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
54 Kobayashi M, Suzuki M, Ikeda H, Takahashi H, Matsumoto N, Maeyama S, Sase S, Iino S, Itoh F. Assessment of hepatic steatosis and hepatic tissue blood flow by xenon computed tomography in nonalcoholic steatohepatitis. Hepatol Res. 2009;39:31-39. [PMID: 18761681 DOI: 10.1111/j.1872-034x.2008.00407.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
55 Sugimoto K, Shiraishi J, Moriyasu F, Ichimura S, Metoki R, Doi K. Analysis of intrahepatic vascular morphological changes of chronic liver disease for assessment of liver fibrosis stages by micro-flow imaging with contrast-enhanced ultrasound: preliminary experience. Eur Radiol. 2010;20:2749-2757. [PMID: 20571803 DOI: 10.1007/s00330-010-1852-1] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
56 Garcea G, Ong SL, Maddern GJ. Predicting liver failure following major hepatectomy. Dig Liver Dis. 2009;41:798-806. [PMID: 19303376 DOI: 10.1016/j.dld.2009.01.015] [Cited by in Crossref: 39] [Cited by in F6Publishing: 37] [Article Influence: 3.3] [Reference Citation Analysis]
57 Wang Y, Booth CJ, Kim H, Qiu M, Constable RT. Evaluation of hepatic fibrosis with portal pressure gradient in rats. Magn Reson Med 2009;61:1185-92. [PMID: 19253377 DOI: 10.1002/mrm.21964] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
58 Guan S, Zhao WD, Zhou KR, Peng WJ, Mao J, Tang F. CT perfusion at early stage of hepatic diffuse disease. World J Gastroenterol 2005;11:3465-7. [PMID: 15948256 DOI: 10.3748/wjg.v11.i22.3465] [Cited by in CrossRef: 23] [Cited by in F6Publishing: 22] [Article Influence: 1.4] [Reference Citation Analysis]
59 Chen BB, Shih TT. DCE-MRI in hepatocellular carcinoma-clinical and therapeutic image biomarker. World J Gastroenterol 2014;20:3125-34. [PMID: 24695624 DOI: 10.3748/wjg.v20.i12.3125] [Cited by in CrossRef: 35] [Cited by in F6Publishing: 32] [Article Influence: 5.8] [Reference Citation Analysis]
60 Do RK, Rusinek H, Taouli B. Dynamic contrast-enhanced MR imaging of the liver: current status and future directions. Magn Reson Imaging Clin N Am. 2009;17:339-349. [PMID: 19406362 DOI: 10.1016/j.mric.2009.01.009] [Cited by in Crossref: 41] [Cited by in F6Publishing: 36] [Article Influence: 3.4] [Reference Citation Analysis]
61 Marsousi N, Desmeules JA, Rudaz S, Daali Y. Usefulness of PBPK Modeling in Incorporation of Clinical Conditions in Personalized Medicine. Journal of Pharmaceutical Sciences 2017;106:2380-91. [DOI: 10.1016/j.xphs.2017.04.035] [Cited by in Crossref: 38] [Cited by in F6Publishing: 27] [Article Influence: 9.5] [Reference Citation Analysis]
62 Yoshimoto T, Kotoh K, Horikawa Y, Kohjima M, Morizono S, Yamashita S, Enjoji M, Nakamuta M. Decreased portal flow volume increases the area of necrosis caused by radio frequency ablation in pigs. Liver Int 2007;27:368-72. [DOI: 10.1111/j.1478-3231.2007.01454.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
63 Berzigotti A, Seijo S, Reverter E, Bosch J. Assessing portal hypertension in liver diseases. Expert Rev Gastroenterol Hepatol. 2013;7:141-155. [PMID: 23363263 DOI: 10.1586/egh.12.83] [Cited by in Crossref: 144] [Cited by in F6Publishing: 98] [Article Influence: 18.0] [Reference Citation Analysis]
64 Chen BB, Hsu CY, Yu CW, Liang PC, Hsu C, Hsu CH, Cheng AL, Shih TT. Dynamic Contrast-enhanced MR Imaging of Advanced Hepatocellular Carcinoma: Comparison with the Liver Parenchyma and Correlation with the Survival of Patients Receiving Systemic Therapy. Radiology. 2016;281:454-464. [PMID: 27171020 DOI: 10.1148/radiol.2016152659] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 3.4] [Reference Citation Analysis]
65 Lewin M, Poujol-Robert A, Boëlle PY, Wendum D, Lasnier E, Viallon M, Guéchot J, Hoeffel C, Arrivé L, Tubiana JM. Diffusion-weighted magnetic resonance imaging for the assessment of fibrosis in chronic hepatitis C. Hepatology. 2007;46:658-665. [PMID: 17663420 DOI: 10.1002/hep.21747] [Cited by in Crossref: 199] [Cited by in F6Publishing: 175] [Article Influence: 14.2] [Reference Citation Analysis]
66 George SM, Eckert LM, Martin DR, Giddens DP. Hemodynamics in Normal and Diseased Livers: Application of Image-Based Computational Models. Cardiovasc Eng Tech 2015;6:80-91. [DOI: 10.1007/s13239-014-0195-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
67 Zhou IY, Catalano OA, Caravan P. Advances in functional and molecular MRI technologies in chronic liver diseases. J Hepatol 2020;73:1241-54. [PMID: 32585160 DOI: 10.1016/j.jhep.2020.06.020] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
68 Bekheit M, Audebert C, Bucur P, Adriaensen H, Bled E, Wartenberg M, Vignon-clementel I, Vibert E. Transit time ultrasound perivascular flow probe technology is superior to MR imaging on hepatic blood flow measurement in a porcine model. Hepatobiliary & Pancreatic Diseases International 2018;17:538-45. [DOI: 10.1016/j.hbpd.2018.07.009] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
69 Eisenbrey JR, Dave JK, Halldorsdottir VG, Merton DA, Miller C, Gonzalez JM, Machado P, Park S, Dianis S, Chalek CL. Chronic liver disease: noninvasive subharmonic aided pressure estimation of hepatic venous pressure gradient. Radiology. 2013;268:581-588. [PMID: 23525208 DOI: 10.1148/radiol.13121769] [Cited by in Crossref: 45] [Cited by in F6Publishing: 30] [Article Influence: 5.6] [Reference Citation Analysis]
70 Taguchi K, Miyasato M, Watanabe H, Sakai H, Tsuchida E, Horinouchi H, Kobayashi K, Maruyama T, Otagiri M. Alteration in the Pharmacokinetics of Hemoglobin-Vesicles in a Rat Model of Chronic Liver Cirrhosis Is Associated with Kupffer Cell Phagocyte Activity. Journal of Pharmaceutical Sciences 2011;100:775-83. [DOI: 10.1002/jps.22286] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
71 Coenegrachts K, Ghekiere J, Denolin V, Gabriele B, Hérigault G, Haspeslagh M, Daled P, Bipat S, Stoker J, Rigauts H. Perfusion maps of the whole liver based on high temporal and spatial resolution contrast-enhanced MRI (4D THRIVE): Feasibility and initial results in focal liver lesions. European Journal of Radiology 2010;74:529-35. [DOI: 10.1016/j.ejrad.2009.03.029] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
72 Takahashi H, Shigefuku R, Yoshida Y, Ikeda H, Matsunaga K, Matsumoto N, Okuse C, Sase S, Itoh F, Suzuki M. Correlation between hepatic blood flow and liver function in alcoholic liver cirrhosis. World J Gastroenterol 2014;20:17065-74. [PMID: 25493018 DOI: 10.3748/wjg.v20.i45.17065] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
73 Sourbron S, Sommer WH, Reiser MF, Zech CJ. Combined quantification of liver perfusion and function with dynamic gadoxetic acid-enhanced MR imaging. Radiology. 2012;263:874-883. [PMID: 22623698 DOI: 10.1148/radiol.12110337] [Cited by in Crossref: 91] [Cited by in F6Publishing: 75] [Article Influence: 10.1] [Reference Citation Analysis]
74 Chandarana H, Taouli B. Diffusion and perfusion imaging of the liver. Eur J Radiol. 2010;76:348-358. [PMID: 20399054 DOI: 10.1016/j.ejrad.2010.03.016] [Cited by in Crossref: 64] [Cited by in F6Publishing: 49] [Article Influence: 5.8] [Reference Citation Analysis]
75 Yzet T, Bouzerar R, Baledent O, Renard C, Lumbala DM, Nguyen-Khac E, Regimbeau JM, Deramond H, Meyer ME. Dynamic measurements of total hepatic blood flow with Phase Contrast MRI. Eur J Radiol 2010;73:119-24. [PMID: 19008062 DOI: 10.1016/j.ejrad.2008.09.032] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
76 Roldán-Alzate A, Frydrychowicz A, Said A, Johnson KM, Francois CJ, Wieben O, Reeder SB. Impaired regulation of portal venous flow in response to a meal challenge as quantified by 4D flow MRI. J Magn Reson Imaging. 2015;42:1009-1017. [PMID: 25772828 DOI: 10.1002/jmri.24886] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 4.2] [Reference Citation Analysis]
77 Wang T, Liang F, Zhou Z, Qi X. Global sensitivity analysis of hepatic venous pressure gradient (HVPG) measurement with a stochastic computational model of the hepatic circulation. Computers in Biology and Medicine 2018;97:124-36. [DOI: 10.1016/j.compbiomed.2018.04.017] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
78 Haninec AL, Voskas D, Needles A, Brown AS, Foster FS, Dumont DJ. Transgenic expression of Angiopoietin 1 in the liver leads to changes in lymphatic and blood vessel architecture. Biochem Biophys Res Commun 2006;345:1299-307. [PMID: 16730659 DOI: 10.1016/j.bbrc.2006.04.149] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
79 Bonekamp S, Kamel I, Solga S, Clark J. Can imaging modalities diagnose and stage hepatic fibrosis and cirrhosis accurately? J Hepatol. 2009;50:17-35. [PMID: 19022517 DOI: 10.1016/j.jhep.2008.10.016] [Cited by in Crossref: 128] [Cited by in F6Publishing: 107] [Article Influence: 9.8] [Reference Citation Analysis]
80 Golse N, Joly F, Combari P, Lewin M, Nicolas Q, Audebert C, Samuel D, Allard MA, Sa Cunha A, Castaing D, Cherqui D, Adam R, Vibert E, Vignon-Clementel IE. Predicting the risk of post-hepatectomy portal hypertension using a digital twin: A clinical proof of concept. J Hepatol 2021;74:661-9. [PMID: 33212089 DOI: 10.1016/j.jhep.2020.10.036] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
81 Bali MA, Metens T, Denolin V, De Maertelaer V, Devière J, Matos C. Pancreatic perfusion: noninvasive quantitative assessment with dynamic contrast-enhanced MR imaging without and with secretin stimulation in healthy volunteers--initial results. Radiology. 2008;247:115-121. [PMID: 18292476 DOI: 10.1148/radiol.2471070685] [Cited by in Crossref: 43] [Cited by in F6Publishing: 38] [Article Influence: 3.3] [Reference Citation Analysis]
82 Taouli B, Koh DM. Diffusion-weighted MR imaging of the liver. Radiology. 2010;254:47-66. [PMID: 20032142 DOI: 10.1148/radiol.09090021] [Cited by in Crossref: 575] [Cited by in F6Publishing: 459] [Article Influence: 52.3] [Reference Citation Analysis]
83 Edginton AN, Willmann S. Physiology-based simulations of a pathological condition: prediction of pharmacokinetics in patients with liver cirrhosis. Clin Pharmacokinet 2008;47:743-52. [PMID: 18840029 DOI: 10.2165/00003088-200847110-00005] [Cited by in Crossref: 104] [Cited by in F6Publishing: 86] [Article Influence: 8.7] [Reference Citation Analysis]
84 Wáng YXJ, Wang X, Wu P, Wang Y, Chen W, Chen H, Li J. Topics on quantitative liver magnetic resonance imaging. Quant Imaging Med Surg 2019;9:1840-90. [PMID: 31867237 DOI: 10.21037/qims.2019.09.18] [Cited by in Crossref: 9] [Cited by in F6Publishing: 16] [Article Influence: 4.5] [Reference Citation Analysis]
85 Vizzutti F, Arena U, Rega L, Pinzani M. Non invasive diagnosis of portal hypertension in cirrhotic patients. Gastroenterol Clin Biol. 2008;32:80-87. [PMID: 18973850 DOI: 10.1016/s0399-8320(08)73997-6] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
86 Li B, Jara H, Yu H, O'Brien M, Soto J, Anderson SW. Enhanced Laws textures: A potential MRI surrogate marker of hepatic fibrosis in a murine model. Magn Reson Imaging 2017;37:33-40. [PMID: 27856399 DOI: 10.1016/j.mri.2016.11.008] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
87 Stankovic Z, Csatari Z, Deibert P, Euringer W, Blanke P, Kreisel W, Abdullah Zadeh Z, Kallfass F, Langer M, Markl M. Normal and altered three-dimensional portal venous hemodynamics in patients with liver cirrhosis. Radiology. 2012;262:862-873. [PMID: 22357888 DOI: 10.1148/radiol.11110127] [Cited by in Crossref: 51] [Cited by in F6Publishing: 42] [Article Influence: 5.7] [Reference Citation Analysis]
88 Annet L, Peeters F, Abarca-Quinones J, Leclercq I, Moulin P, Van Beers BE. Assessment of diffusion-weighted MR imaging in liver fibrosis. J Magn Reson Imaging. 2007;25:122-128. [PMID: 17154179 DOI: 10.1002/jmri.20771] [Cited by in Crossref: 115] [Cited by in F6Publishing: 99] [Article Influence: 8.2] [Reference Citation Analysis]
89 Keller S, Aigner A, Zenouzi R, Kim AC, Meijer A, Weidemann SA, Krech T, Lohse AW, Adam G, Schramm C, Yamamura J. Association of gadolinium-enhanced magnetic resonance imaging with hepatic fibrosis and inflammation in primary sclerosing cholangitis. PLoS One. 2018;13:e0193929. [PMID: 29513767 DOI: 10.1371/journal.pone.0193929] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
90 Fischer MA, Donati OF, Reiner CS, Hunziker R, Nanz D, Boss A. Feasibility of semiquantitative liver perfusion assessment by ferucarbotran bolus injection in double-contrast hepatic MRI. J Magn Reson Imaging 2012;36:168-76. [PMID: 22334302 DOI: 10.1002/jmri.23611] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
91 Tarantino G, Citro V, Conca P, Riccio A, Tarantino M, Capone D, Cirillo M, Lobello R, Iaccarino V. What are the implications of the spontaneous spleno-renal shunts in liver cirrhosis? BMC Gastroenterol. 2009;9:89. [PMID: 19930687 DOI: 10.1186/1471-230x-9-89] [Cited by in Crossref: 64] [Cited by in F6Publishing: 32] [Article Influence: 5.3] [Reference Citation Analysis]
92 Wang D, Jin B, Lewandowski RJ, Ryu RK, Sato KT, Mulcahy MF, Kulik LM, Miller FH, Salem R, Li D, Omary RA, Larson AC. Quantitative 4D transcatheter intraarterial perfusion MRI for monitoring chemoembolization of hepatocellular carcinoma. J Magn Reson Imaging 2010;31:1106-16. [PMID: 20432345 DOI: 10.1002/jmri.22155] [Cited by in Crossref: 20] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
93 Zhang L, Duan Y, Li J, Yin J. Hemodynamic Features of Doppler Ultrasonography in Patients With Portal Hypertension: Intraoperative Direct Measurement of Portal Pressure in the Portal Venous System. Journal of Ultrasound in Medicine 2007;26:1689-96. [DOI: 10.7863/jum.2007.26.12.1689] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
94 Taouli B, Johnson RS, Hajdu CH, Oei MT, Merad M, Yee H, Rusinek H. Hepatocellular carcinoma: perfusion quantification with dynamic contrast-enhanced MRI. AJR Am J Roentgenol. 2013;201:795-800. [PMID: 24059368 DOI: 10.2214/ajr.12.9798] [Cited by in Crossref: 59] [Cited by in F6Publishing: 32] [Article Influence: 7.4] [Reference Citation Analysis]
95 Leporq B, Dumortier J, Pilleul F, Beuf O. 3D-liver perfusion MRI with the MS-325 blood pool agent: A noninvasive protocol to asses liver fibrosis. J Magn Reson Imaging 2012;35:1380-7. [DOI: 10.1002/jmri.23594] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
96 Procopet B, Berzigotti A. Diagnosis of cirrhosis and portal hypertension: imaging, non-invasive markers of fibrosis and liver biopsy. Gastroenterol Rep (Oxf). 2017;5:79-89. [PMID: 28533906 DOI: 10.1093/gastro/gox012] [Cited by in Crossref: 62] [Cited by in F6Publishing: 42] [Article Influence: 15.5] [Reference Citation Analysis]
97 Ronot M, Lambert S, Daire J, Lagadec M, Doblas S, Garteiser P, Kerbaol A, Sinkus R, Van Beers B, Vilgrain V. Can we justify not doing liver perfusion imaging in 2013? Diagnostic and Interventional Imaging 2013;94:1323-36. [DOI: 10.1016/j.diii.2013.06.005] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
98 Hindel S, Geisel D, Alerić I, Theilig D, Denecke T, Lüdemann L. Liver function quantification of patients with portal vein embolization using dynamic contrast-enhanced MRI for assessment of hepatocyte uptake and elimination. Phys Med 2020;76:207-20. [PMID: 32707485 DOI: 10.1016/j.ejmp.2020.07.002] [Reference Citation Analysis]
99 Ozkurt H, Keskiner F, Karatag O, Alkim C, Erturk SM, Basak M. Diffusion Weighted MRI for Hepatic Fibrosis: Impact of b-Value. Iran J Radiol 2014;11:e3555. [PMID: 24693297 DOI: 10.5812/iranjradiol.3555] [Cited by in Crossref: 4] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
100 Stankovic Z, Csatari Z, Deibert P, Euringer W, Jung B, Kreisel W, Geiger J, Russe MF, Langer M, Markl M. A feasibility study to evaluate splanchnic arterial and venous hemodynamics by flow-sensitive 4D MRI compared with Doppler ultrasound in patients with cirrhosis and controls. Eur J Gastroenterol Hepatol. 2013;25:669-675. [PMID: 23411868 DOI: 10.1097/meg.0b013e32835e1297] [Cited by in Crossref: 26] [Cited by in F6Publishing: 15] [Article Influence: 3.3] [Reference Citation Analysis]
101 Padhani AR, Weinreb J, Rosenkrantz AB, Villeirs G, Turkbey B, Barentsz J. Prostate Imaging-Reporting and Data System Steering Committee: PI-RADS v2 Status Update and Future Directions. Eur Urol 2019;75:385-96. [PMID: 29908876 DOI: 10.1016/j.eururo.2018.05.035] [Cited by in Crossref: 106] [Cited by in F6Publishing: 87] [Article Influence: 35.3] [Reference Citation Analysis]
102 Kim SY, Jeong WK, Kim Y, Heo JN, Kim MY, Kim TY, Sohn JH. Changing waveform during respiration on hepatic vein Doppler sonography of severe portal hypertension: comparison with the damping index. J Ultrasound Med 2011;30:455-62. [PMID: 21460144 DOI: 10.7863/jum.2011.30.4.455] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
103 Talakić E, Schaffellner S, Kniepeiss D, Mueller H, Stauber R, Quehenberger F, Schoellnast H. CT perfusion imaging of the liver and the spleen in patients with cirrhosis: Is there a correlation between perfusion and portal venous hypertension? Eur Radiol 2017;27:4173-80. [PMID: 28321540 DOI: 10.1007/s00330-017-4788-x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
104 Bosch J, Berzigotti A, Garcia-Pagan JC, Abraldes JG. The management of portal hypertension: rational basis, available treatments and future options. J Hepatol. 2008;48 Suppl 1:S68-S92. [PMID: 18304681 DOI: 10.1016/j.jhep.2008.01.021] [Cited by in Crossref: 190] [Cited by in F6Publishing: 145] [Article Influence: 14.6] [Reference Citation Analysis]
105 Aguirre-Reyes DF, Sotelo JA, Arab JP, Arrese M, Tejos R, Irarrazaval P, Tejos C, Uribe SA, Andia ME. Intrahepatic portal vein blood volume estimated by non-contrast magnetic resonance imaging for the assessment of portal hypertension. Magn Reson Imaging 2015;33:970-7. [PMID: 26117696 DOI: 10.1016/j.mri.2015.06.016] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
106 Liu Q, Ma K, Song Y, Zhou N, He Z. Two-year follow-up of splenic radiofrequency ablation in patients with cirrhotic hypersplenism: does increased hepatic arterial flow induce liver regeneration? Surgery 2008;143:509-18. [PMID: 18374048 DOI: 10.1016/j.surg.2007.11.016] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
107 Leitão HS, Doblas S, d'Assignies G, Garteiser P, Daire JL, Paradis V, Geraldes CF, Vilgrain V, Van Beers BE. Fat deposition decreases diffusion parameters at MRI: a study in phantoms and patients with liver steatosis. Eur Radiol 2013;23:461-7. [PMID: 22935901 DOI: 10.1007/s00330-012-2626-8] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 2.6] [Reference Citation Analysis]
108 Chaves IJ, Rigsby CK, Schoeneman SE, Kim ST, Superina RA, Ben-Ami T. Pre- and postoperative imaging and interventions for the meso-Rex bypass in children and young adults. Pediatr Radiol. 2012;42:220-32; quiz 271. [PMID: 22037931 DOI: 10.1007/s00247-011-2283-0] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
109 Schaffner D, von Elverfeldt D, Deibert P, Lazaro A, Merfort I, Lutz L, Neubauer J, Baumstark MW, Kreisel W, Reichardt W. Phase-contrast MR flow imaging: A tool to determine hepatic hemodynamics in rats with a healthy, fibrotic, or cirrhotic liver. J Magn Reson Imaging 2017;46:1526-34. [PMID: 28240794 DOI: 10.1002/jmri.25677] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
110 Martin DR, Lauenstein T, Kalb B, Lurie C, Kitajima H, Sharma P, Salman K, Moreira R, Farris AB 3rd, Spivey J, Martinez E, Hanish S, Adsay V. Liver MRI and histological correlates in chronic liver disease on multiphase gadolinium-enhanced 3D gradient echo imaging. J Magn Reson Imaging 2012;36:422-9. [PMID: 22566123 DOI: 10.1002/jmri.23668] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
111 Saito K, Ledsam J, Sourbron S, Hashimoto T, Araki Y, Akata S, Tokuuye K. Measuring hepatic functional reserve using low temporal resolution Gd-EOB-DTPA dynamic contrast-enhanced MRI: a preliminary study comparing galactosyl human serum albumin scintigraphy with indocyanine green retention. Eur Radiol. 2014;24:112-119. [PMID: 23949726 DOI: 10.1007/s00330-013-2983-y] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 3.6] [Reference Citation Analysis]
112 Baxter S, Wang ZJ, Joe BN, Qayyum A, Taouli B, Yeh BM. Timing bolus dynamic contrast-enhanced (DCE) MRI assessment of hepatic perfusion: Initial experience. J Magn Reson Imaging. 2009;29:1317-1322. [PMID: 19472388 DOI: 10.1002/jmri.21795] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 2.3] [Reference Citation Analysis]
113 Peeters F, Annet L, Hermoye L, Van Beers BE. Inflow correction of hepatic perfusion measurements usingT1-weighted, fast gradient-echo, contrast-enhanced MRI. Magn Reson Med 2004;51:710-7. [DOI: 10.1002/mrm.20032] [Cited by in Crossref: 46] [Cited by in F6Publishing: 40] [Article Influence: 2.7] [Reference Citation Analysis]
114 Jajamovich GH, Huang W, Besa C, Li X, Afzal A, Dyvorne HA, Taouli B. DCE-MRI of hepatocellular carcinoma: perfusion quantification with Tofts model versus shutter-speed model--initial experience. MAGMA 2016;29:49-58. [PMID: 26646522 DOI: 10.1007/s10334-015-0513-4] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
115 Salameh N, Peeters F, Sinkus R, Abarca-quinones J, Annet L, ter Beek LC, Leclercq I, Van Beers BE. Hepatic viscoelastic parameters measured with MR elastography: Correlations with quantitative analysis of liver fibrosis in the rat. J Magn Reson Imaging 2007;26:956-62. [DOI: 10.1002/jmri.21099] [Cited by in Crossref: 68] [Cited by in F6Publishing: 50] [Article Influence: 4.9] [Reference Citation Analysis]
116 Bane O, Hectors SJ, Wagner M, Arlinghaus LL, Aryal MP, Cao Y, Chenevert TL, Fennessy F, Huang W, Hylton NM, Kalpathy‐cramer J, Keenan KE, Malyarenko DI, Mulkern RV, Newitt DC, Russek SE, Stupic KF, Tudorica A, Wilmes LJ, Yankeelov TE, Yen Y, Boss MA, Taouli B. Accuracy, repeatability, and interplatform reproducibility of T 1 quantification methods used for DCE‐MRI: Results from a multicenter phantom study. Magn Reson Med 2018;79:2564-75. [DOI: 10.1002/mrm.26903] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 9.5] [Reference Citation Analysis]
117 Aramburu J, Antón R, Rivas A, Ramos JC, Sangro B, Bilbao JI. Liver cancer arterial perfusion modelling and CFD boundary conditions methodology: a case study of the haemodynamics of a patient-specific hepatic artery in literature-based healthy and tumour-bearing liver scenarios: Liver Cancer Arterial Perfusion Modelling. Int J Numer Meth Biomed Engng 2016;32:e02764. [DOI: 10.1002/cnm.2764] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 3.6] [Reference Citation Analysis]
118 Kim H, Booth CJ, Pinus AB, Chen P, Lee A, Qiu M, Whitlock M, Murphy PS, Constable RT. Induced Hepatic Fibrosis in Rats: Hepatic Steatosis, Macromolecule Content, Perfusion Parameters, and Their Correlations—Preliminary MR Imaging in Rats. Radiology 2008;247:696-705. [DOI: 10.1148/radiol.2473070605] [Cited by in Crossref: 37] [Cited by in F6Publishing: 36] [Article Influence: 2.8] [Reference Citation Analysis]
119 Takahashi H, Suzuki M, Shigefuku R, Okano M, Hiraishi T, Takagi R, Noguchi Y, Hattori N, Hatsugai M, Nakahara K. Xenon computed tomography can evaluate the improvement of hepatic hemodynamics before and after endoscopic injection sclerotherapy. J Gastroenterol. 2013;48:1353-1361. [PMID: 23397117 DOI: 10.1007/s00535-013-0756-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
120 Jajamovich GH, Calcagno C, Dyvorne HA, Rusinek H, Taouli B. DCE-MRI of the liver: reconstruction of the arterial input function using a low dose pre-bolus contrast injection. PLoS One 2014;9:e115667. [PMID: 25546176 DOI: 10.1371/journal.pone.0115667] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
121 Helmke S, Colmenero J, Everson GT. Noninvasive assessment of liver function. Curr Opin Gastroenterol. 2015;31:199-208. [PMID: 25714706 DOI: 10.1097/mog.0000000000000167] [Cited by in Crossref: 20] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
122 Glockner JF. Hepatobiliary MRI: current concepts and controversies. J Magn Reson Imaging. 2007;25:681-695. [PMID: 17352396 DOI: 10.1002/jmri.20844] [Cited by in Crossref: 22] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
123 Kekelidze M, D’Errico L, Pansini M, Tyndall A, Hohmann J. Colorectal cancer: current imaging methods and future perspectives for the diagnosis, staging and therapeutic response evaluation. World J Gastroenterol. 2013;19:8502-8514. [PMID: 24379567 DOI: 10.3748/wjg.v19.i46.8502] [Cited by in CrossRef: 77] [Cited by in F6Publishing: 57] [Article Influence: 11.0] [Reference Citation Analysis]
124 Pandharipande PV, Krinsky GA, Rusinek H, Lee VS. Perfusion imaging of the liver: current challenges and future goals. Radiology. 2005;234:661-673. [PMID: 15734925 DOI: 10.1148/radiol.2343031362] [Cited by in Crossref: 220] [Cited by in F6Publishing: 188] [Article Influence: 13.8] [Reference Citation Analysis]
125 Hagiwara M, Rusinek H, Lee VS, Losada M, Bannan MA, Krinsky GA, Taouli B. Advanced liver fibrosis: diagnosis with 3D whole-liver perfusion MR imaging--initial experience. Radiology. 2008;246:926-934. [PMID: 18195377 DOI: 10.1148/radiol.2463070077] [Cited by in Crossref: 177] [Cited by in F6Publishing: 164] [Article Influence: 13.6] [Reference Citation Analysis]
126 Shigefuku R, Takahashi H, Kato M, Yoshida Y, Suetani K, Noguchi Y, Hatsugai M, Nakahara K, Ikeda H, Kobayashi M. Evaluation of hepatic tissue blood flow using xenon computed tomography with fibrosis progression in nonalcoholic fatty liver disease: comparison with chronic hepatitis C. Int J Mol Sci. 2014;15:1026-1039. [PMID: 24424317 DOI: 10.3390/ijms15011026] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
127 Park HS, Desser TS, Jeffrey RB, Kamaya A. Doppler Ultrasound in Liver Cirrhosis: Correlation of Hepatic Artery and Portal Vein Measurements With Model for End-Stage Liver Disease Score: Doppler Ultrasound in Liver Cirrhosis. J Ultrasound Med 2017;36:725-30. [DOI: 10.7863/ultra.16.03107] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
128 Bakan AA, Inci E, Bakan S, Gokturk S, Cimilli T. Utility of diffusion-weighted imaging in the evaluation of liver fibrosis. Eur Radiol. 2012;22:682-687. [PMID: 21984447 DOI: 10.1007/s00330-011-2295-z] [Cited by in Crossref: 52] [Cited by in F6Publishing: 46] [Article Influence: 5.2] [Reference Citation Analysis]
129 Gressner OA, Weiskirchen R, Gressner AM. Biomarkers of hepatic fibrosis, fibrogenesis and genetic pre-disposition pending between fiction and reality. J Cell Mol Med. 2007;11:1031-1051. [PMID: 17979881 DOI: 10.1111/j.1582-4934.2007.00092.x] [Cited by in Crossref: 69] [Cited by in F6Publishing: 61] [Article Influence: 5.3] [Reference Citation Analysis]
130 Alvarez J, Baluja A, Selas S, Otero P, Rial M, Veiras S, Caruezo V, Laboada M, Rodriguez I, Caslroagudin J, Lome S, Rodriguez A, Rodriguez J. A Comparison of Doubutamine and Levosimendan on Hepatic Blood Flow in Patients with a Low Cardiac Output State after Cardiac Surgery: A Randomised Controlled Study. Anaesth Intensive Care 2013;41:719-27. [DOI: 10.1177/0310057x1304100606] [Cited by in Crossref: 12] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
131 Procopet B, Berzigotti A. New Tools for the Noninvasive Assessment of Cirrhosis. Curr Hepatology Rep. [DOI: 10.1007/s11901-014-0210-1] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
132 Taouli B, Tolia AJ, Losada M, Babb JS, Chan ES, Bannan MA, Tobias H. Diffusion-weighted MRI for quantification of liver fibrosis: preliminary experience. AJR Am J Roentgenol. 2007;189:799-806. [PMID: 17885048 DOI: 10.2214/ajr.07.2086] [Cited by in Crossref: 265] [Cited by in F6Publishing: 92] [Article Influence: 18.9] [Reference Citation Analysis]
133 Sgouros SN, Vasiliadis KV, Pereira SP. Systematic review: endoscopic and imaging-based techniques in the assessment of portal haemodynamics and the risk of variceal bleeding. Alimentary Pharmacology & Therapeutics 2009;30:965-76. [DOI: 10.1111/j.1365-2036.2009.04135.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
134 Stojković MV, Artiko VM, Radoman IB, Knezević SJ, Lukić SM, Kerkez MD, Lekić NS, Antić AA, Zuvela MM, Ranković VI, Petrović MN, Sobić DP, Obradović VB. Color Doppler sonography and angioscintigraphy in hepatic Hodgkin's lymphoma. World J Gastroenterol 2009;15:3269-75. [PMID: 19598303 DOI: 10.3748/wjg.15.3269] [Cited by in CrossRef: 2] [Article Influence: 0.2] [Reference Citation Analysis]
135 Kim SU, Kim YC, Choi JS, Kim KS, Choi GH, Choi JS, Park JY, Kim do Y, Ahn SH, Choi EH. Can preoperative diffusion-weighted MRI predict postoperative hepatic insufficiency after curative resection of HBV-related hepatocellular carcinoma? A pilot study. Magn Reson Imaging. 2010;28:802-811. [PMID: 20395100 DOI: 10.1016/j.mri.2010.03.018] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
136 Aguirre DA, Behling CA, Alpert E, Hassanein TI, Sirlin CB. Liver Fibrosis: Noninvasive Diagnosis with Double Contrast Material–enhanced MR Imaging. Radiology 2006;239:425-37. [DOI: 10.1148/radiol.2392050505] [Cited by in Crossref: 143] [Cited by in F6Publishing: 133] [Article Influence: 9.5] [Reference Citation Analysis]
137 Kim KA, Park MS, Kim IS, Kiefer B, Chung WS, Kim MJ, Kim KW. Quantitative evaluation of liver cirrhosis using T1 relaxation time with 3 tesla MRI before and after oxygen inhalation. J Magn Reson Imaging. 2012;36:405-410. [PMID: 22392835 DOI: 10.1002/jmri.23620] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 4.1] [Reference Citation Analysis]
138 Pinzani M. Non-invasive evaluation of hepatic fibrosis: don’t count your chickens before they’re hatched. Gut. 2006;55:310-312. [PMID: 16474104 DOI: 10.1136/gut.2005.068585] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 2.2] [Reference Citation Analysis]
139 Kennedy P, Bane O, Hectors SJ, Fischman A, Schiano T, Lewis S, Taouli B. Noninvasive imaging assessment of portal hypertension. Abdom Radiol 2020;45:3473-95. [DOI: 10.1007/s00261-020-02729-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
140 Do RK, Chandarana H, Felker E, Hajdu CH, Babb JS, Kim D, Taouli B. Diagnosis of liver fibrosis and cirrhosis with diffusion-weighted imaging: Value of normalized apparent diffusion coefficient using the spleen as reference organ. AJR Am J Roentgenol. 2010;195:671-676. [PMID: 20729445 DOI: 10.2214/ajr.09.3448] [Cited by in Crossref: 96] [Cited by in F6Publishing: 33] [Article Influence: 8.7] [Reference Citation Analysis]
141 Abdullah SS, Pialat JB, Wiart M, Duboeuf F, Mabrut JY, Bancel B, Rode A, Ducerf C, Baulieux J, Berthezene Y. Characterization of hepatocellular carcinoma and colorectal liver metastasis by means of perfusion MRI. J Magn Reson Imaging. 2008;28:390-395. [PMID: 18666145 DOI: 10.1002/jmri.21429] [Cited by in Crossref: 43] [Cited by in F6Publishing: 40] [Article Influence: 3.3] [Reference Citation Analysis]
142 Mandorfer M, Hernández-Gea V, García-Pagán JC, Reiberger T. Noninvasive Diagnostics for Portal Hypertension: A Comprehensive Review. Semin Liver Dis 2020;40:240-55. [PMID: 32557480 DOI: 10.1055/s-0040-1708806] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 10.0] [Reference Citation Analysis]
143 Qu EZ, Zhang YC, Li ZY, Liu Y, Wang JR. Contrast-enhanced sonography for quantitative assessment of portal hypertension in patients with liver cirrhosis. J Ultrasound Med. 2014;33:1971-1977. [PMID: 25336484 DOI: 10.7863/ultra.33.11.1971] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
144 Thng CH, Koh TS, Collins D, Koh DM. Perfusion imaging in liver MRI. Magn Reson Imaging Clin N Am 2014;22:417-32. [PMID: 25086937 DOI: 10.1016/j.mric.2014.04.011] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
145 Peeters G, Debbaut C, Cornillie P, De Schryver T, Monbaliu D, Laleman W, Segers P. A Multilevel Modeling Framework to Study Hepatic Perfusion Characteristics in Case of Liver Cirrhosis. Journal of Biomechanical Engineering 2015;137:051007. [DOI: 10.1115/1.4029280] [Cited by in Crossref: 21] [Cited by in F6Publishing: 11] [Article Influence: 3.5] [Reference Citation Analysis]
146 Nilsson H, Blomqvist L, Douglas L, Nordell A, Janczewska I, Näslund E, Jonas E. Gd-EOB-DTPA-enhanced MRI for the assessment of liver function and volume in liver cirrhosis. Br J Radiol 2013;86:20120653. [PMID: 23403453 DOI: 10.1259/bjr.20120653] [Cited by in Crossref: 49] [Cited by in F6Publishing: 46] [Article Influence: 6.1] [Reference Citation Analysis]
147 Yuan F, Song B, Huang Z, Liu X, Xia C. Glucose as a stimulation agent in the BOLD functional magnetic resonance imaging for liver cirrhosis and hepatocellular carcinoma: a feasibility study. Abdom Radiol (NY) 2018;43:607-12. [PMID: 28730273 DOI: 10.1007/s00261-017-1264-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
148 Chen BB, Hsu CY, Yu CW, Wei SY, Kao JH, Lee HS, Shih TT. Dynamic contrast-enhanced magnetic resonance imaging with Gd-EOB-DTPA for the evaluation of liver fibrosis in chronic hepatitis patients. Eur Radiol. 2012;22:171-180. [PMID: 21879400 DOI: 10.1007/s00330-011-2249-5] [Cited by in Crossref: 77] [Cited by in F6Publishing: 76] [Article Influence: 7.7] [Reference Citation Analysis]
149 Lin Y, Hwang R, Chen B, Hsu C, Yu C, Kao J, Lee H, Liang P, Wei S, Shih TT. Vascular and hepatic enhancements at MR imaging: comparison of Gd-EOB-DTPA and Gd-DTPA in the same subjects. Clinical Imaging 2014;38:287-91. [DOI: 10.1016/j.clinimag.2014.01.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
150 Zhou L, Wang LY, Zhang XM, Zeng NL, Chen TW, Li R, Huang YC, Tang YL. Semi-quantitative assessment of the presence and Child-Pugh class of hepatitis B related cirrhosis by using liver lobe-based dynamic contrast-enhanced MRI. Clin Radiol 2016;71:1289-95. [PMID: 27633724 DOI: 10.1016/j.crad.2016.07.017] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
151 Jin N, Deng J, Chadashvili T, Zhang Y, Guo Y, Zhang Z, Yang GY, Omary RA, Larson AC. Carbogen gas-challenge BOLD MR imaging in a rat model of diethylnitrosamine-induced liver fibrosis. Radiology. 2010;254:129-137. [PMID: 20032147 DOI: 10.1148/radiol.09090410] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 2.7] [Reference Citation Analysis]
152 McAvoy NC, Semple S, Richards JM, Robson AJ, Patel D, Jardine AG, Leyland K, Cooper AS, Newby DE, Hayes PC. Differential visceral blood flow in the hyperdynamic circulation of patients with liver cirrhosis. Aliment Pharmacol Ther. 2016;43:947-954. [PMID: 26947424 DOI: 10.1111/apt.13571] [Cited by in Crossref: 28] [Cited by in F6Publishing: 20] [Article Influence: 5.6] [Reference Citation Analysis]
153 Takahashi H, Suzuki M, Ikeda H, Kobayashi M, Sase S, Yotsuyanagi H, Maeyama S, Iino S, Itoh F. Evaluation of quantitative portal venous, hepatic arterial, and total hepatic tissue blood flow using xenon CT in alcoholic liver cirrhosis-comparison with liver cirrhosis related to hepatitis C virus and nonalcoholic steatohepatitis. Alcohol Clin Exp Res. 2010;34 Suppl 1:S7-S13. [PMID: 18986379 DOI: 10.1111/j.1530-0277.2008.00755.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
154 Dyvorne HA, Knight-Greenfield A, Besa C, Cooper N, Garcia-Flores J, Schiano TD, Markl M, Taouli B. Quantification of hepatic blood flow using a high-resolution phase-contrast MRI sequence with compressed sensing acceleration. AJR Am J Roentgenol 2015;204:510-8. [PMID: 25714279 DOI: 10.2214/AJR.14.12597] [Cited by in Crossref: 10] [Cited by in F6Publishing: 1] [Article Influence: 1.7] [Reference Citation Analysis]
155 Sandrasegaran K, Akisik FM, Lin C, Tahir B, Rajan J, Saxena R, Aisen AM. Value of diffusion-weighted MRI for assessing liver fibrosis and cirrhosis. AJR Am J Roentgenol. 2009;193:1556-1560. [PMID: 19933647 DOI: 10.2214/ajr.09.2436] [Cited by in Crossref: 147] [Cited by in F6Publishing: 46] [Article Influence: 13.4] [Reference Citation Analysis]
156 Garcia-tsao G. Portal hypertension: . Current Opinion in Gastroenterology 2005;21:313-22. [DOI: 10.1097/01.mog.0000158110.13722.e0] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
157 Ippolito D, Colombo M, Trattenero C, Bonaffini PA, Talei Franzesi C, Fior D, Sironi S. Diagnostic Value of Semiquantitative Analysis of Dynamic Susceptibility Contrast Magnetic Resonance Imaging with GD-EOB-DTPA in Focal Liver Lesions Characterization: A Feasibility Study. Gastroenterol Res Pract. 2015;2015:630273. [PMID: 26064093 DOI: 10.1155/2015/630273] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
158 Scalera JE, Soto JA, Jara H, Ozonoff A, O'Brien M, Anderson SW. Multiexponential T(2) analyses in a murine model of hepatic fibrosis at 11.7 T MRI. NMR Biomed 2013;26:83-90. [PMID: 22674663 DOI: 10.1002/nbm.2822] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
159 Haider MA, Farhadi FA, Milot L. Hepatic perfusion imaging: concepts and application. Magn Reson Imaging Clin N Am 2010;18:465-75, x. [PMID: 21094450 DOI: 10.1016/j.mric.2010.07.009] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
160 Aubé C. Imaging modalities for the diagnosis of hepatic fibrosis and cirrhosis. Clin Res Hepatol Gastroenterol. 2015;39:38-44. [PMID: 25037179 DOI: 10.1016/j.clinre.2014.06.006] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 1.9] [Reference Citation Analysis]
161 McDonald N, Lilburn DML, Lachlan NJ, Macnaught G, Patel D, Jayaswal ANA, Hayes PC, Semple SI, Fallowfield JA. Assessment of Haemodynamic Response to Nonselective Beta-Blockers in Portal Hypertension by Phase-Contrast Magnetic Resonance Angiography. Biomed Res Int 2017;2017:9281450. [PMID: 28698881 DOI: 10.1155/2017/9281450] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
162 Ikeda H, Suzuki M, Kobayashi M, Takahashi H, Matsumoto N, Maeyama S, Iino S, Sase S, Itoh F. Xenon computed tomography shows hemodynamic change during the progression of chronic hepatitis C. Hepatol Res. 2007;37:104-112. [PMID: 17300705 DOI: 10.1111/j.1872-034x.2007.00020.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
163 Verloh N, Haimerl M, Rennert J, Müller-Wille R, Nießen C, Kirchner G, Scherer MN, Schreyer AG, Stroszczynski C, Fellner C. Impact of liver cirrhosis on liver enhancement at Gd-EOB-DTPA enhanced MRI at 3 Tesla. Eur J Radiol. 2013;82:1710-1715. [PMID: 23806531 DOI: 10.1016/j.ejrad.2013.05.033] [Cited by in Crossref: 47] [Cited by in F6Publishing: 45] [Article Influence: 5.9] [Reference Citation Analysis]
164 Liang PC, Ch’ang HJ, Hsu C, Tseng SS, Shih TT, Wu Liu T. Dynamic MRI signals in the second week of radiotherapy relate to treatment outcomes of hepatocellular carcinoma: a preliminary result. Liver Int. 2007;27:516-528. [PMID: 17403192 DOI: 10.1111/j.1478-3231.2007.01456.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
165 Girometti R, Furlan A, Esposito G, Bazzocchi M, Como G, Soldano F, Isola M, Toniutto P, Zuiani C. Relevance of b-values in evaluating liver fibrosis: a study in healthy and cirrhotic subjects using two single-shot spin-echo echo-planar diffusion-weighted sequences. J Magn Reson Imaging. 2008;28:411-419. [PMID: 18666139 DOI: 10.1002/jmri.21461] [Cited by in Crossref: 84] [Cited by in F6Publishing: 72] [Article Influence: 6.5] [Reference Citation Analysis]
166 Haktanir A, Cihan BS, Celenk C, Cihan S. Value of Doppler sonography in assessing the progression of chronic viral hepatitis and in the diagnosis and grading of cirrhosis. J Ultrasound Med 2005;24:311-21. [PMID: 15723843 DOI: 10.7863/jum.2005.24.3.311] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 1.9] [Reference Citation Analysis]
167 Liang PC, Ch’ang HJ, Hsu C, Chen LT, Shih TT, Liu TW. Perfusion parameters of dynamic contrast-enhanced magnetic resonance imaging predict outcomes of hepatocellular carcinoma receiving radiotherapy with or without thalidomide. Hepatol Int. 2015;9:258-268. [PMID: 25788178 DOI: 10.1007/s12072-014-9557-1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
168 Tu R, Xia LP, Yu AL, Wu L. Assessment of hepatic functional reserve by cirrhosis grading and liver volume measurement using CT. World J Gastroenterol 2007;13:3956-61. [PMID: 17663509 DOI: 10.3748/wjg.v13.i29.3956] [Cited by in CrossRef: 28] [Cited by in F6Publishing: 20] [Article Influence: 2.0] [Reference Citation Analysis]
169 Mathew RP, Venkatesh SK. Imaging of Hepatic Fibrosis. Curr Gastroenterol Rep 2018;20. [DOI: 10.1007/s11894-018-0652-7] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
170 Hughes-Cassidy F, Chavez AD, Schlang A, Hassanein T, Gamst A, Wolfson T, Sirlin C. Superparamagnetic iron oxides and low molecular weight gadolinium chelates are synergistic for direct visualization of advanced liver fibrosis. J Magn Reson Imaging. 2007;26:728-737. [PMID: 17685418 DOI: 10.1002/jmri.21066] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.2] [Reference Citation Analysis]
171 Bradley CR, Cox EF, Scott RA, James MW, Kaye P, Aithal GP, Francis ST, Guha IN. Multi-organ assessment of compensated cirrhosis patients using quantitative magnetic resonance imaging. J Hepatol. 2018;69:1015-1024. [PMID: 29886155 DOI: 10.1016/j.jhep.2018.05.037] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 7.0] [Reference Citation Analysis]
172 Turnes J, Garcia-pagan JC, Bosch J. What else we need. In: Groszmann RJ, Bosch J, editors. Portal Hypertension in the 21st Century. Dordrecht: Springer Netherlands; 2004. pp. 349-60. [DOI: 10.1007/978-94-007-1042-9_35] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
173 Thng CH, Koh TS, Collins DJ, Koh DM. Perfusion magnetic resonance imaging of the liver. World J Gastroenterol. 2010;16:1598-1609. [PMID: 20355238 DOI: 10.3748/wjg.v16.i13.1598] [Cited by in CrossRef: 74] [Cited by in F6Publishing: 63] [Article Influence: 6.7] [Reference Citation Analysis]
174 Schramm N, D’anastasi M, Reiser M, Zech C. Stellenwert der MRT bei diffusen Lebererkrankungen. Radiologe 2012;52:727-37. [DOI: 10.1007/s00117-012-2310-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
175 Hoefs JC, Chen PT, Lizotte P. Noninvasive evaluation of liver disease severity. Clin Liver Dis 2006;10:535-62, viii-ix. [PMID: 17162227 DOI: 10.1016/j.cld.2006.08.008] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
176 Sommer WH, Sourbron S, Huppertz A, Ingrisch M, Reiser MF, Zech CJ. Contrast agents as a biological marker in magnetic resonance imaging of the liver: conventional and new approaches. Abdom Imaging. 2012;37:164-179. [PMID: 21516381 DOI: 10.1007/s00261-011-9734-9] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
177 Miyazaki K, Orton MR, Davidson RL, d’Arcy JA, Lewington V, Koh TS, Thng CH, Leach MO, Collins DJ, Koh DM. Neuroendocrine tumor liver metastases: use of dynamic contrast-enhanced MR imaging to monitor and predict radiolabeled octreotide therapy response. Radiology. 2012;263:139-148. [PMID: 22344403 DOI: 10.1148/radiol.12110770] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 3.4] [Reference Citation Analysis]
178 Ma R, Hunter P, Cousins W, Ho H, Bartlett A, Safaei S. Anatomically based simulation of hepatic perfusion in the human liver. Int J Numer Meth Biomed Engng 2019;35. [DOI: 10.1002/cnm.3229] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
179 Van Beers BE, Doblas S, Sinkus R. New acquisition techniques: fields of application. Abdom Imaging 2012;37:155-63. [PMID: 21584637 DOI: 10.1007/s00261-011-9748-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]